Gastroenterology & Nutrition | Parenteral Nutrition
Specific Clinical Situations Underlying Special Needs
Provided below are problems (and possible solutions
for those problems) associated with each of the following:
Problems
Body Mass Index is a recently employed methodology for
evaluating body composition. Body mass index is determined
by the formula: weight(kg)/ height(m) x height(m). Graphs of
BMI versus age are readily available to determine where an
individual patient plots at any particular age. A BMI above
expected normals indicates that a patient's body composition
is not normal, usually because weight exceeds what is
expected for height at a particular age. Excessive weight
may be caused by:
- excess body fat
- edema
- comparmentalized fluid such as ascites or effusion
These excesses contribute to body weight, but not to
metabolic activity. Calculations with body weight assume
that body composition is normal, consisting of 70 to 75%
lean body mass and 25 to 30% fat mass. Lean body mass is the
energy-consuming compartment of the body. Thus, using excess
weight to calculate energy expenditures results in an
overestimation of energy needs since the increased weight is
assumed to contain 70 to 75% metabolically active tissue.
Solutions
To estimate energy expenditure accurately when BMI is high,
calculations of energy expenditure should employ ideal body
weight for height or length rather than actual body weight.
Ideal body weight(IBW) can be determined by:
- Employing the BMI formula: Ideal body weight(kg)
= BMI (50%tile for age) x height(m) x height (m)
BMI for Girls
[chart]
BMI for Boys
[chart]
- Using normal growth charts: Ideal body weight(kg)
= weight at the 50%tile for the actual height or length
at the patient's age
Girls 0-36 Months Growth Chart
[growth chart]
Girls 2-20 Years Growth Chart
[growth chart]
Boys 0-36 Months Growth Chart
[growth chart]
Boys 2-20 Years Growth Chart
[growth chart]
- Another location to access BMI and Growth Charts:
CDC compilation of BMI and Growth Charts
[clinical charts]
The use of ideal body weight results in a more accurate
determination of actual resting and total daily energy
expenditures. Thus, when the BMI exceeds the expected value
for age, the IBW should be substituted for the actual body
weight when performing calculations of energy expenditure
and nutritional needs.
Problems
Solutions
Additional fluid and/or electrolyte administered as a separate
IV solution through a Y-connector with TPN. As fluid and salt
needs change, these supplemental fluids can be altered in amount
and type without interruption of nutritional support.
Problems
- pre- or post-operative congenital heart disease
- renal failure
- severe lung disease with cor pulmonale
Solutions
PN is provided via central access. Peripheral PN cannot be
designed to provide sufficient energy intake to justify use.
Special solutions with high concentrations of dextrose (> 30%)
and amino acids (AAM > 30 gm/L) may be needed.
The nutrition literature is replete with various recommendations for
increasing energy intake in patients with underlying disease.
Documentation of increased energy needs has accumulated for only a
few specific conditions:
Problems
Infection without fever, post-operative status, or
trauma may not necessitate any calorie increase above
the usual requirements. Even with extra needs, TDEE does
not usually exceed 2.0 x REE.
Solutions
Carefully considered inceases in energy intake are achievable.
Generally, glucose infusion rates should not exceed 20
mg/kg/min, and IL infusion rates should not exceed 0.1
gm/kg/hour.
(See also
Nutrition Literature Resource)
Many patients with severe underlying disease actually consume less
energy than would be expected.
Problems
- mechanically ventilated patients
- paralyzed patients
- comatose patients
- patients with markedly altered body composition, e.g.
obese children with profound neurological impairment
Solutions
When estimating energy requirements, begin with measured,
calculated, or estimated REE and do not assume extra needs for
underlying illness.
Mild alterations is serum concentrations of sodium, potassium,
calcium, phosphorus, magnesium, and albumin are common in ill
patients. Often, these abnormalities will improve with remission of
the basic illness and routine TPN support. Special adjustments of PN
solutions are not necessary.
| Diagnosis |
Problem |
Potential Solutions
|
|
|
Cardiac, renal and liver transplant
|
| |
Fluid restrictions
|
Increase nutrient concentrations
|
| |
Hyperglycemia
|
Monitor glucose homeostasis. Substitute IL for glucose
for calories. Initiate insulin.
|
| |
Hypomagnesemia
|
Increase amount in PN
|
| |
Hypoalbuminemia
|
Albumin infusion if ascites or effusions compromise patient
|
| |
Cyclosporin infusion
|
Not compatible with PN solutions. Switch to enteral route.
|
|
Congenital cardiac disease
|
| |
Diuretics produce hypokalemia, hypomagnesemia, or hypocalcemia
|
Provide supplemental electrolytes, magnesium, or calcium
|
| |
Magnesium depletion prolongs hypokalemia
|
Provide additional magnesium. Monitor serum magnesium levels.
|
| |
Higher energy needs
|
Increase glucose concentration or add IL
|
| |
Fluid restrictions
|
Central PN required
|
|
Liver synthetic dysfunction
|
| |
Hypalbuminemia
|
Albumin infusion only if ascites & edema compromise
respiration or comfort
|
| |
Hyponatremia
|
May not require specific therapy. May indicate hepatorenal syndrome
|
| |
Coagulopathy
|
Assure vitamin K delivery. Refractory bleeding requires FFP
or factor infusion
|
| |
Hyperammonemia
|
Lactulose or neomycin enterally if encephalopathic
|
| |
Hypoglycemia
|
Avoid interruption of glucose infusion
|
|
Chronic lung disease
|
| |
Compensatory metabolic alkalosis
|
No specific therapy
|
| |
Diuretics produce hypokalemia
|
Supplement potassiium
|
| |
Hypercarbia
|
Reduce glucose infusion rate & supply IL
|
| |
Hypoalbuminemia
|
Often dilutional, not nutritional
|
|
Neurologic disorder
|
| |
Elevated serum transaminases
|
Often occurs with anti-convulsants
|
| |
Paralysis and/or coma
|
Reduce energy intake
|
| |
Constant chorea or seizures
|
Increase energy intake
|
|
Oncologic disease
|
| |
Tumor lysis syndrome with elevated phosphorus and uric acid
|
Special fluid management, allopurinol, and alkalinization
|
| |
Hypomagnesemia
|
Provide additional magnesium
|
| |
Limited oral intake
|
Continue PN
|
|
Intestinal surgery
[reference]
|
| |
High nasogastric tube output
|
Replace with supplemental electrolyte solution
|
| |
High ostomy output
|
Replace with supplemental electrolyte solution
|
| |
Infection
|
Tailored antibiotics
|
|
Renal failure
|
| |
Fluid restriction
|
Central PN required. Provide IL for supplemental energy.
|
| |
Azotemia
|
Review with Pediatric Nephrology
|
| |
Hyperkalemia or hyperphosphatemia
|
Adjust PN constituents
|
|
Intrahepatic cholestasis
|
| |
Elevated direct or conjugated & delta bilirubin
|
Consider potential contributing etiologies, e.g. infection,
obstuction, etc.
|
| |
|
Promote bile flow with enteral feeds
|
|